Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

Triple-negative breast cancer (TNBC) shows a very bad prognosis, even in early stages of disease. Metronomic chemotherapy refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen with no prolonged drug-free breaks that leads to antitumor activity...

Full description

Saved in:
Bibliographic Details
Main Authors: M. E. Cazzaniga, L. Cortesi, A. Ferzi, L. Scaltriti, F. Cicchiello, M. Ciccarese, S. Della Torre, F. Villa, M. Giordano, C. Verusio, M. Nicolini, A. R. Gambaro, L. Zanlorenzi, E. Biraghi, E. Casini, L. Legramandi, E. Rulli
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2017/1683060
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2017/1683060

Similar Items